[1]EuropeanJournalofMedicinalChemistry,2016,vol.122,p.723-730
[1]CurrentPatentAssignee:SHANGHAIZHEYEBIOTECHNOLOGY-CN108341837,2018,ALocationinpatent:Paragraph0128;0132
18135-04-1
18187-24-1 | Disiloxane, 1,3-dimethoxy-1,1,3,3-tetramethyl- | AA00232R | MFCD01861727
18212-27-6 | 3-[1,2,3]Thiadiazol-4-yl-pyridine | AA0023BZ | MFCD11501091
1824276-05-2 | 3-(Trifluoromethyl)quinolin-5-amine | AA0023SO | MFCD28133478
1829-40-9 | Disiloxane, 1,1,1,3,3,3-hexaphenyl- | AA00245C | MFCD00014068
17629-30-0 | α-D-Glucopyranoside, β-D-fructofuranosyl O-α-D-galactopyranosyl-(1→6)-, hydrate (1:5) | AA0024HE | MFCD00149452
176796-64-8 | 1,2-Benzenedicarboxylic acid, 4-(aminocarboxymethyl)- | AA0024TX | MFCD06798364
1772-25-4 | 1,3,6-Hexanetricarbonitrile | AA00253C | MFCD00129792
17766-28-8 | 1-Cyclohexylpiperazine | AA0025DN | MFCD03434391
177985-33-0 | 2-Chloro-5-fluorophenylacetic acid | AA0025MC | MFCD01016155
1783503-14-9 | 2-(2-Chlorothiazol-5-yl)ethanol | AA0025VR | MFCD27922904